AUDIOCURE PHARMA
AudioCure Pharma is a pharmaceutical company with a focus on hearing impairments. Operational since 2012, AudioCure was founded by Professor Hans Rommelspacher; a clinician and academic who has dedicated his career to the discovery and preclinical development of drug candidates. He is joined by highly skilled scientists and executives as well as a tight-knit network of academic partners, internationally renowned advisors and strategic investors. AudioCure is based in Berlin, Germany. Their offi... ce is located in a peaceful courtyard in the central area of Mitte. As such, they benefit from being within easy reach of the main train station and many other Berlin high-tech companies and universities while also enjoying the hustle and bustle of this vibrant capital city. They have close ties to the Charité University which allows for a close interaction with the experts of this world renowned institution. Their front-runner compound: AC102, is currently in late stage preclinical development for the treatment of acute noise-induced hearing loss having successfully demonstrated preclinical proof of concept in 2016.
AUDIOCURE PHARMA
Social Links:
Industry:
Biotechnology Education Emergency Medicine Therapeutics
Founded:
2010-01-01
Address:
Berlin, Berlin, Germany
Country:
Germany
Website Url:
http://www.audiocure.com
Total Employee:
1+
Status:
Active
Contact:
+49 (30) 221 8397 14
Email Addresses:
[email protected]
Total Funding:
9 M EUR
Technology used in webpage:
LetsEncrypt Nginx CrUX Dataset CrUX Top 10m Common Name Invalid Infomaniak Network
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Inception Sciences
Inception Sciences creates therapies with transformative potential to address diseases and disorders with significant unmet need.
Current Employees Featured
Founder
Investors List
HTGF | High-Tech Gruenderfonds
HTGF | High-Tech Gruenderfonds investment in Series A - AudioCure Pharma
MED-EL
MED-EL investment in Series A - AudioCure Pharma
HTGF | High-Tech Gruenderfonds
HTGF | High-Tech Gruenderfonds investment in Seed Round - AudioCure Pharma
Jürgen Schumacher
Jürgen Schumacher investment in Seed Round - AudioCure Pharma
Official Site Inspections
http://www.audiocure.com
- Host name: w00.rzone.de
- IP address: 81.169.145.64
- Location: Berlin Germany
- Latitude: 52.5174
- Longitude: 13.3985
- Timezone: Europe/Berlin
- Postal: 12529
More informations about "AudioCure Pharma"
About Us - Audiocure
Operational since 2012, AudioCure was founded by Professor Hans Rommelspacher; a clinician and academic who has dedicated his career to the discovery and preclinical development of …See details»
AudioCure Pharma - Crunchbase Company Profile
AudioCure Pharma is a pharmaceutical company with a focus on hearing impairments. Operational since 2012, AudioCure was founded by Professor Hans Rommelspacher; a clinician and academic who has dedicated his career to …See details»
Audiocure - Company Profile - Tracxn
Feb 17, 2024 Audiocure - Drug development for hearing disorders with a high unmet medical need. Raised a total funding of $9.56M over 2 rounds from 2 investors. Founded by Hans …See details»
AudioCure Pharma - Overview, News & Competitors | ZoomInfo.com
AudioCure Pharma contact info: Phone number: +49 493027594394 Website: www.audiocure.com What does AudioCure Pharma do? AudioCure Pharma GmbH is a …See details»
AudioCure Pharma Company Profile - Office Locations ... - Craft
AudioCure Pharma has 5 employees at their 1 location and $10.58 m in total funding,. See insights on AudioCure Pharma including office locations, competitors, revenue, financials, …See details»
AudioCure Pharma - The Org
AudioCure is dedicated to the development of drug treatments for hearing disorders with a high unmet medical need.See details»
AudioCure Pharma - Products, Competitors, Financials, Employees ...
AudioCure Pharma is a pharmaceutical company focused on developing drug treatments for hearing disorders. The company's main offerings include novel pharmacotherapies aimed at …See details»
AudioCure Pharma GmbH | Insights
Contract Research Organization-CRO; Biotechnology; See more in Biomedtracker. Latest on AudioCure Pharma GmbH. Already A Biomedtracker Subscriber? You have access to the full …See details»
AudioCure Pharma Awarded for Therapeutic Small Molecule for …
Dec 7, 2023 AudioCure is conducting extensive research to develop targeted and effective therapies to address this high unmet medical need. “The Innovator Awards aim to …See details»
Sudden Hearing Loss Study Reaches Milestone: AudioCure Pharma …
BERLIN, November 26, 2024--Berlin-based start-up AudioCure Pharma has enrolled more than 50% of the planned patients in its ongoing Phase 2 clinical trial. The aim of the study is to test …See details»
Our Technology - Audiocure
AudioCure Pharma develops novel pharmaceutical therapies for the prevention and treatment of a range of hearing impairments with high, unmet medical need. Our lead candidate is a novel …See details»
AudioCure Pharma Receives Hearing Technology Innovator Award …
BERLIN, December 07, 2023--AudioCure's AC102 receives Hearing Technology Innovator Award for groundbreaking hearing loss treatment. A pan-European Phase 2 trial is ongoing.See details»
AudioCure Advances AC102 Trial to Treat Sudden Hearing Loss
Nov 26, 2024 Summary: Berlin-based AudioCure Pharma has surpassed 50% patient enrollment in its Phase 2 trial testing AC102, a novel therapy targeting sensory cells and synaptic …See details»
Compound AC102 Shows Promise in Restoring Noise-Induced …
Apr 1, 2024 A single application of the novel compound AC102 almost completely restores noise-induced hearing loss in preclinical models. This is the key finding of a recent publication …See details»
Sudden Hearing Loss Study Reaches Milestone: AudioCure
Nov 26, 2024 Berlin-based start-up AudioCure Pharma has enrolled more than 50% of the planned patients in its ongoing Phase 2 clinical trial. The aim of the study is to test the efficacy …See details»
Recruitment of Sudden Hearing Loss Patients for Clinical Trial: …
Nov 30, 2023 To address this high unmet medical need, AudioCure Pharma is developing the investigative medicine AC102, which is applied via single intratympanic injection (A) and …See details»
Newsroom – Audiocure
AudioCure welcomes your interest in our company. Keep up to date with the latest news, events and press releases here:See details»
AC102 - Audiocure
AC102: A Novel Candidate Compound for Sudden Hearing Loss. AudioCure’s candidate compound is named AC102. The primary focus of AudioCure’s development program for …See details»
How We Hear - Audiocure
Hearing is the access to the world surrounding us and key for communication and forming human connections. Hearing starts with sound entering the ear canal where it leads to vibrations of …See details»